Department of Public Health, College of Medicine, Tzu Chi University, Hualien, Taiwan.
Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
BMC Complement Med Ther. 2020 Jul 30;20(1):240. doi: 10.1186/s12906-020-03032-0.
The use of Chinese herbal medicine (CHM) has been widely promoted as a natural and safe way to treat illness during pregnancy. However, prescription patterns and factors influencing its use are largely unknown. Therefore, we conducted a population-based study to address these questions.
Pregnant women aged 18-50 years were selected from Taiwan's National Health Insurance Research Database between 2001 to 2011. CHM prescriptions and diagnostic records were collected. Demographic data and pre-existing diseases were compared between CHM users and non-users. A multivariate logistic regression analysis was performed to identify possible factors influencing the use of CHM during pregnancy.
A total of 81,873 eligible prescription records were identified, and 16,553 pregnant women were prescribed CHM during pregnancy, yielding a CHM prescription rate of 20.2%. The three most frequently used herbs were Scutellariae Radix (Huang Qin) (4.4%), Eucommiae cortex (Du Zhong) (2.5%), and Atractylodes Rhizome (Bai Zhu) (2.4%). The most frequently used herbal formulae were Dang-Guei-Shao-Yao-San (4.1%), Jia-Wei-Xiao-Yao-San (3.5%), and Xiang-Sha-Liu-Jun-Zi-Tang (2.6%). Multivariate logistic regression revealed that subjects with an older age, a university education, a pre-pregnancy history of CHM use, asthma, chronic renal disease, and cardiac valvular disease and living in a residential area other than northern Taiwan had an increase in adjusted odds ratio for CHM use during pregnancy.
In this population-based study, we found that demographic factors and pre-existing diseases were associated with the use of CHM among pregnant women. It is worth noting that Leonuri Herba (Yi Mu Cao) and Shao-Fu-Zhu-Yu-Tang should be used with caution in the first trimester. Further research is needed to explore the safety and effectiveness of the use of CHM in pregnant women.
中草药(CHM)的使用已被广泛推广为治疗孕期疾病的天然和安全方式。然而,其处方模式和影响其使用的因素在很大程度上尚不清楚。因此,我们进行了一项基于人群的研究来解决这些问题。
我们从 2001 年至 2011 年的台湾全民健康保险研究数据库中选择了 18-50 岁的孕妇。收集了 CHM 处方和诊断记录。比较了 CHM 用户和非用户的人口统计学数据和既往疾病。使用多变量逻辑回归分析来确定可能影响孕期 CHM 使用的因素。
共确定了 81873 份合格的处方记录,有 16553 名孕妇在孕期开具了 CHM 处方,CHM 处方率为 20.2%。使用最多的三种草药是黄芩(Huang Qin)(4.4%)、杜仲(Du Zhong)(2.5%)和白术(Bai Zhu)(2.4%)。使用最多的草药方剂是当归芍药散(Dang-Guei-Shao-Yao-San)(4.1%)、加味逍遥散(Jia-Wei-Xiao-Yao-San)(3.5%)和香砂六君子汤(Xiang-Sha-Liu-Jun-Zi-Tang)(2.6%)。多变量逻辑回归显示,年龄较大、受过大学教育、有孕前 CHM 使用史、哮喘、慢性肾脏病、心脏瓣膜病和居住在台湾北部以外地区的孕妇,其孕期使用 CHM 的调整优势比增加。
在这项基于人群的研究中,我们发现人口统计学因素和既往疾病与孕妇使用 CHM 有关。值得注意的是,益母草(Yi Mu Cao)和少腹逐瘀汤(Shao-Fu-Zhu-Yu-Tang)应在孕早期谨慎使用。需要进一步研究来探索孕妇使用 CHM 的安全性和有效性。